Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences.

Research output: Contribution to journalArticlepeer-review

40 Citations (SciVal)
353 Downloads (Pure)

Abstract

Predicting any future metastatic site of early-stage breast cancer is important as it significantly influences the prognosis of advanced disease. This study aimed at investigating the potential of claudin-2, over-expressed in breast cancer liver metastases, as a biomarker for predicting liver metastatic propensity in primary breast cancer.
Original languageEnglish
Pages (from-to)119-128
JournalMolecular Oncology
Volume8
Issue number1
DOIs
Publication statusPublished - 2014

Subject classification (UKÄ)

  • Cancer and Oncology

Fingerprint

Dive into the research topics of 'Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences.'. Together they form a unique fingerprint.

Cite this